SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-011022
Filing Date
2017-05-15
Accepted
2017-05-15 16:02:48
Documents
3
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 1Q17 fate-8k_20170514.htm 8-K 32590
2 EX-99.1 fate-ex991_24.htm EX-99.1 126178
3 GRAPHIC g201705151451147011374.jpg GRAPHIC 3659
  Complete submission text file 0001564590-17-011022.txt   165141
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 17844117
SIC: 2836 Biological Products, (No Diagnostic Substances)